‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
In Practice: Patient-reported experiences survey GP feedback is being sought on whether patient-reported measures are acceptable, appropriate and meaningful in the general practice context.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
In Practice: Member forum on governance The RACGP is inviting members attending GP24 to join a governance discussion to help shape the future of the college.
New PBS listing for high-risk CVD patients Experts welcome the listing of Vazkepa, with the treatment aimed at reducing heart attack risks for statin-treated patients with high triglycerides.
Action taken amid continuing PrEP shortage As supply of the HIV prevention medication continues to be disrupted, the Federal Government has listed a US brand on the PBS to shore up access.
City PBS prescription rates double those in very remote areas One GP says there simply are not enough remote doctors, as new data finds the people living there are accessing medication at a much lower rate.
Admin burden top reason GPs plan to leave practice: RACGP In a ‘wakeup call’ for governments, the new Health of the Nation report found 70% of GPs are concerned about their admin workload.
Final 60-day dispensing medicines revealed Around 100 extra medicines are now available for 60-day prescriptions, including treatments for asthma, COPD, anxiety and Parkinson’s disease.
‘Join this century’: Call for change amid growing GP red tape The RACGP is demanding a solution from the Commonwealth after presenting it with a long list of cumbersome ways its services are burdening time-poor GPs.